Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 41 Colorectal Neoplasms 15 Lung Neoplasms 12 Ovarian Neoplasms 6 Stomach Neoplasms 5 Pancreatic Neoplasms 5 Neoplasms 5 Rectal Neoplasms 4 Neoplasm Metastasis 4 Melanoma 4 Colonic Neoplasms 4 Carcinoma, Renal Cell 4 Triple Negative Breast Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Recurrence 3 Mesothelioma 3 Carcinoma, Pancreatic Ductal 3 Peritoneal Neoplasms 2 Fallopian Tube Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Breast Neoplasms 2 Vipoma 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Spinocerebellar Degenerations 1 Somatostatinoma 1 Skin Neoplasms 1

Interventions

Radiotherapy 4 Immune Checkpoint Inhibitors 4 famitinib 1 camrelizumab 1 aflutinib 1 Oxaliplatin 1 Nivolumab 1 Ipilimumab 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced NSCLC × Oxaliplatin × Thoracic × Clear all

NCT04043195 2025-05-28

NSCLC

University of California, San Diego

Phase 1/2 Active not recruiting

Advanced NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡